
Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
Drugs Safety AlertFDA Issues Safety Warning: Transderm Scop (Scopolamine Transdermal System) Antinausea Patch May Cause Heat-Related Illness, Hospitalization, or DeathJune 22, 2025Category: Drug Safety Alerts | FDA Updates | Patient Safety Written by: Priyanka Khamkar, MPharm Reviewed By: Pharmacally Editorial…Fact-Checked
Clinical TrialsIbezapolstat: AcurX Pharmaceuticals First-in-Class Mechanism Antibiotic for Clostridioides difficile Infection Shows Promising Results in Phase 2b TrialPublished On: 20 June 2025 Category: Clinical Trial I Infectious Disease I Gut and Gastrointestinal Infections Written By: Pharmacally Medical…Fact-Checked
Disease & DrugsVenclexta Falls Short in Late-Stage Trial for Higher-Risk Myelodysplastic Syndrome (MDS): Roche and AbbVie Release ResultsPublished: June 18, 2025 Category: Clinical Trial | Hematology | Oncology Written By: Team Pharmacally…Fact-Checked
Disease & DrugsAfter Second Liver Failure Death, Sarepta Therapeutics Halts Global Elevidys Dosing in Non-Ambulatory Duchenne Muscular Dystrophy Patients; Phase III ENVISION Trial ImpactedMedically Written and Reviewed By: Vikas Londhe, MPharm Source: Freepik.com On June 15, 2025, Sarepta Therapeutics announced the second death…Fact-Checked
New Drug ApprovalModerna Launches mNEXSPIKE: New FDA-Approved COVID Vaccine for High-Risk GroupsIn a landmark move, the FDA has granted approval to Moderna’s mNEXSPIKE, marking a new chapter in COVID-19 vaccine evolution.Fact-Checked
ResearchThe Hidden Pain Pathway: Paracetamol (Acetaminophen) Metabolite AM404 Blocks Peripheral Sodium Channels – A New Mechanism UncoveredMedically Written and Reviewed By: Vikas Londhe, M.Pharm, Pharmacology Source: Freepik.com For over a century, paracetamol (acetaminophen) has been one…Fact-Checked
New Drug ApprovalYutrepia (Treprostinil) Inhalation Powder developed on Liquidia’s PRINT technology Gets FDA Approval for Pulmonary Hypertension and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)Yutrepia is an FDA-approved, inhaled dry-powder dosage form of treprostinil for treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).Fact-Checked
Research“Treating Spinal Muscular Atrophy (SMA) in the Womb: Early Evidence for Prenatal Risdiplam Therapy”Spinal muscular atrophy (SMA) is a rare but serious genetic neuromuscular disorder characterized by the degeneration of motor neurons in the spinal cord.Fact-Checked
Research“Saarvienin A: A Novel Antibiotic from Rare Earth Mine in China Targets Vancomycin-Resistant Gram-Positive Bacteria”The growing threat of antimicrobial resistance (AMR) strengthens the urgent need to search for novel therapeutic agents.Fact-Checked
Clinical TrialsBeyond Weight Loss: First-Generation GLP-1 Drugs Like Liraglutide and Exenatide Show Promising Anti-Cancer EffectsObesity is a major global health concern and a known risk factor for at least 13 different types of cancer.Fact-Checked
ResearchRevolutionizing Pancreatic Cancer Detection in just 45 minutes: the PAC-MANN Nanosensor Assay Offers a Low-Cost, High-Accuracy SolutionPancreatic ductal adenocarcinoma (PDAC) is broadly recognized as one of the most fatal forms of cancer, characterized by a low five-year survival rate.Fact-Checked
Research“The Curious Case of KJ: How the World’s First CRISPR-Cas9 Gene Editing Therapy Saved a Child from Fatal CPS1 Deficiency”In a landmark medical breakthrough, a young child identified only as KJ became the first known patient to be successfully treated for a fatal genetic disorder using CRISPR…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.